NASDAQ:AMBI

AMBI (AMBI) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$4.17
$4.60
50-Day Range
N/A
52-Week Range
N/A
Volume
10,575 shs
Average Volume
5,765 shs
Market Capitalization
$235.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
AMBI stock logo

About AMBI Stock (NASDAQ:AMBI)

Ambit Biosciences Corporation is a biopharmaceutical company. The Company focused on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology, autoimmune and inflammatory diseases by inhibiting kinases that are important drivers for those diseases. The Company’s lead drug candidate, quizartinib, is in Phase IIb clinical development in patients with relapsed/refractory acute myeloid leukemia (AML). The Company’s second drug candidate in clinical development, AC410, is a potent, selective, orally-administered, small molecule inhibitor of Janus kinase 2 (JAK2) that has potential utility for the treatment of autoimmune and inflammatory diseases. The Company’s third program consists of two selective small molecule compounds, AC708 and AC855, which inhibit the colony-stimulating factor-1 receptor (CSF1R), a receptor tyrosine kinase.

AMBI Stock News Headlines

He Is Giving Away Bitcoin
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
These 74 robotics companies are hiring
He Is Giving Away Bitcoin
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Sandy Wu's cafe attacked by two men
Navigating the Cosmos
See More Headlines
Receive AMBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AMBI and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/06/2014
Today
4/23/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Sanitary services
Sub-Industry
N/A
Current Symbol
NASDAQ:AMBI
Fax
N/A
Employees
5,041
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$326.33 million
Cash Flow
$5.45 per share
Book Value
$10.21 per share

Miscellaneous

Free Float
26,597,000
Market Cap
$235.49 million
Optionable
Not Optionable
Beta
0.61
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

AMBI Stock Analysis - Frequently Asked Questions

How were AMBI's earnings last quarter?

AMBI (NASDAQ:AMBI) released its quarterly earnings data on Tuesday, May, 6th. The biopharmaceutical company reported ($0.50) EPS for the quarter, missing the consensus estimate of ($0.47) by $0.03. The biopharmaceutical company had revenue of $0.03 million for the quarter, compared to analyst estimates of $3.50 million.

What other stocks do shareholders of AMBI own?
This page (NASDAQ:AMBI) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners